Associate Director, HEOR, Hematology, Europe and New Markets

BeOne Medicines; Basel; Vor Ort; CHF 120.000 - 180.000; Teilzeit

Zusammenfassung

BeOne Medicines in Basel-Stadt, Basel seeks an experienced HEOR professional for a part-time role across Europe and New Markets. You will integrate quickly, manage multiple HEOR projects, and collaborate with Market Access, Medical Affairs, Clinical Development, and Global teams.

The ideal candidate combines strong HEOR capabilities with a pragmatic mindset. You will deliver evidence to support HTA and reimbursement, coordinate with external vendors, and help shape EU JCA strategies in a

Qualifikationen

• Master's degree or PhD in Health Economics, Outcomes Research, Epidemiology or related field.
• 5+ years of HEOR/HTA/RWE experience in pharma or consulting.
• Strong understanding of European HTA requirements; JCA knowledge is a plus.
• Experience with ITC/NMA and MAIC/STC methods is desirable.
• Experience managing external vendors and HEOR studies.
• Hematology/oncology knowledge is a plus.
• Excellent English written and verbal communication.
• Ability to work in a cross-functional matrix and manage multiple priorities.

Aufgaben

• Support HEOR activities across hematology assets in Europe and New Markets, ensuring high‑quality and timely delivery of evidence for HTA, reimbursement and broader needs.
• Collaborate cross-functionally with Market Access, Medical Affairs, Clinical Development, Biostatistics and Global teams to identify evidence gaps and prioritize HEOR activities.
• Develop and execute HEOR evidence-generation activities, including comparative effectiveness research, real‑world evidence, economic analyses and other projects.
• Develop and review study protocols, analysis plans, reports, publications and other HEOR deliverables, ensuring methodological quality and correct interpretation.
• Contribute to European HTA and EU Joint Clinical Assessment (JCA) evidence strategy, including evidence-generation activities for upcoming assessments.
• Support JCA PICO strategy and planning, including populations, subgroups, comparators and outcomes evaluation of evidence gaps.
• Lead or support comparative evidence generation for HTA needs.
• Work with internal teams and external vendors to evaluate available clinical trial, external and real‑world data and address gaps.
• Manage external HEOR vendors and projects, including scope, timelines, deliverables and quality control.
• Support interpretation and communication of HEOR evidence, including uncertainties and implications for HTA.
• Provide additional HEOR support across hematology portfolio as priorities evolve during the contract period.

Kenntnisse

HEOR expertise

HTA knowledge

RWE experience

Cross-functional collaboration

Ausbildung

Master's or PhD in Health Economics / Outcomes Research / Epidemiology / Public Health / Statistics

Jobbeschreibung

About BeOne Medicines

BeOne Medicines is a global oncology company focused on discovering and developing innovative medicines to improve treatment outcomes and access for patients with cancer worldwide. With a growing portfolio and pipeline, BeOne operates in a dynamic, science-driven and highly cross-functional environment.

About BeOne Medicines

BeOne Medicines is a global oncology company focused on discovering and developing innovative medicines to improve treatment outcomes and access for patients with cancer worldwide. With a growing portfolio and pipeline, BeOne operates in a dynamic, science-driven and highly cross-functional environment.

The Europe and New Markets HEOR team works across the hematology portfolio to generate evidence supporting the value of our medicines, European and country-level HTA and reimbursement and broader evidence needs throughout the product lifecycle.

Who We Are Looking For

We are looking for an experienced HEOR professional who can quickly integrate into the team and provide hands‑on support across a range of ongoing and emerging priorities. Given the short term nature of the assignment, the successful candidate should be comfortable rolling up their sleeves, taking ownership of projects and moving work forward with a high degree of independence.

The role requires someone who combines strong technical HEOR capabilities with a pragmatic and solution‑oriented mindset. Excellent communication and stakeholder‑management skills are important, as the individual will work with multiple teams across the organization, including HEOR, Market Access, Medical Affairs, Clinical Development, Biostatistics, Regulatory Affairs and Global functions, as well as external vendors and research partners.

The ideal candidate is comfortable working in a fast‑paced environment where priorities may evolve, can manage several workstreams simultaneously, and knows when to work independently versus when to bring the right stakeholders together to make decisions and resolve issues.

This role is part‑time position

Responsibilities

• Support and manage HEOR activities across hematology assets in Europe and New Markets, ensuring high‑quality and timely delivery of evidence to support HTA, reimbursement and broader evidence needs.
• Work cross‑functionally with Market Access, Medical Affairs, Clinical Development, Biostatistics and Global teams to identify evidence gaps and prioritize HEOR activities according to regional and country needs.
• Support the development and execution of HEOR evidence‑generation activities, including comparative effectiveness research, real‑world evidence, economic analyses and other projects according to business needs.
• Support development and review of study protocols, analysis plans, reports, publications and other HEOR deliverables, ensuring methodological quality and appropriate interpretation of results.
• Contribute to the European HTA and EU Joint Clinical Assessment (JCA) evidence strategy, including preparation and execution of evidence‑generation activities required to support upcoming assessments.
• Support JCA PICO strategy and planning, including assessment of anticipated populations, subgroups, comparators and outcomes, identification of evidence gaps, and evaluation of the feasibility of addressing different PICOs.
• Lead or support comparative evidence generation for JCA and other HTA needs.
• Work with internal teams and external vendors to evaluate available clinical trial, external and real‑world data and determine appropriate approaches to address identified evidence gaps.
• Manage external HEOR vendors and projects, including scope development, methodological review, timelines, deliverables and quality control.len>
• Support interpretation and communication of HEOR evidence, including methodological assumptions, uncertainty, limitations and implications for HTA and evidence strategy.
• Provide additional HEOR support across the hematology portfolio as priorities evolve during the contract period.

Requirements

• Master's degree or PhD in Health Economics, Outcomes Research, Epidemiology, Public Health, Statistics or a related discipline.
• At least 5 years of relevant experience in HEOR, HTA, RWE or comparative effectiveness research, preferably within the pharmaceutical industry or consulting.
• Good understanding of European HTA and evidence requirements; knowledge or experience with the EU HTA Regulation and JCA would be a strong asset.
• Experience with comparative effectiveness methods such as ITC/NMA and population‑adjusted approaches (e.g. MAIC/STC) would be highly desirable.
• Experience designing, managing and critically reviewing HEOR studies and working with external research vendors.
• Knowledge or experience in hematology/oncology would be an asset.
• Strong analytical and critical‑thinking skills, with the ability to translate evidence gaps into practical research activities.
• Ability to work effectively in a cross‑functional matrix environment and manage multiple projects and changing priorities.
• Excellent written and verbal communication skills in English.
• Highly organized, proactive and able to work independently in a fast‑paced environment.